全文获取类型
收费全文 | 109832篇 |
免费 | 9352篇 |
国内免费 | 2698篇 |
专业分类
耳鼻咽喉 | 760篇 |
儿科学 | 2323篇 |
妇产科学 | 936篇 |
基础医学 | 13029篇 |
口腔科学 | 2244篇 |
临床医学 | 11126篇 |
内科学 | 14730篇 |
皮肤病学 | 1620篇 |
神经病学 | 11350篇 |
特种医学 | 3100篇 |
外国民族医学 | 28篇 |
外科学 | 7682篇 |
综合类 | 14918篇 |
现状与发展 | 15篇 |
预防医学 | 12599篇 |
眼科学 | 3186篇 |
药学 | 9537篇 |
110篇 | |
中国医学 | 3440篇 |
肿瘤学 | 9149篇 |
出版年
2024年 | 122篇 |
2023年 | 1835篇 |
2022年 | 2246篇 |
2021年 | 4277篇 |
2020年 | 4375篇 |
2019年 | 3755篇 |
2018年 | 3650篇 |
2017年 | 3741篇 |
2016年 | 3902篇 |
2015年 | 4040篇 |
2014年 | 7103篇 |
2013年 | 7947篇 |
2012年 | 6542篇 |
2011年 | 6909篇 |
2010年 | 5492篇 |
2009年 | 5364篇 |
2008年 | 5550篇 |
2007年 | 5320篇 |
2006年 | 4830篇 |
2005年 | 4193篇 |
2004年 | 3481篇 |
2003年 | 3128篇 |
2002年 | 2597篇 |
2001年 | 2228篇 |
2000年 | 1866篇 |
1999年 | 1581篇 |
1998年 | 1346篇 |
1997年 | 1242篇 |
1996年 | 1106篇 |
1995年 | 1167篇 |
1994年 | 1141篇 |
1993年 | 979篇 |
1992年 | 930篇 |
1991年 | 919篇 |
1990年 | 752篇 |
1989年 | 637篇 |
1988年 | 624篇 |
1987年 | 553篇 |
1986年 | 529篇 |
1985年 | 775篇 |
1984年 | 604篇 |
1983年 | 388篇 |
1982年 | 443篇 |
1981年 | 390篇 |
1980年 | 337篇 |
1979年 | 232篇 |
1978年 | 206篇 |
1977年 | 159篇 |
1976年 | 115篇 |
1975年 | 58篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Zi-Qi Shao Shan-Shan Dou Jun-Ge Zhu Hui-Qing Wang Chun-Mei Wang Bao-Hua Cheng Bo Bai 《中国神经再生研究》2021,16(6):1044
Apelin-13 is a novel endogenous ligand for an angiotensin-like orphan G-protein coupled receptor, and it may be neuroprotective against cerebral ischemia injury. However, the precise mechanisms of the effects of apelin-13 remain to be elucidated. To investigate the effects of apelin-13 on apoptosis and autophagy in models of cerebral ischemia/reperfusion injury, a rat model was established by middle cerebral artery occlusion. Apelin-13(50 μg/kg) was injected into the right ventricle as a treatment. In addition, an SH-SY5 Y cell model was established by oxygen-glucose deprivation/reperfusion, with cells first cultured in sugar-free medium with 95% N2 and 5% CO2 for 4 hours and then cultured in a normal environment with sugar-containing medium for 5 hours. This SH-SY5 Y cell model was treated with 10–7 M apelin-13 for 5 hours. Results showed that apelin-13 protected against cerebral ischemia/reperfusion injury. Apelin-13 treatment alleviated neuronal apoptosis by increasing the ratio of Bcl-2/Bax and significantly decreasing cleaved caspase-3 expression. In addition, apelin-13 significantly inhibited excessive autophagy by regulating the expression of LC3 B, p62, and Beclin1. Furthermore, the expression of Bcl-2 and the phosphatidylinositol-3-kinase(PI3 K)/Akt/mammalian target of rapamycin(mTOR) pathway was markedly increased. Both LY294002(20 μM) and rapamycin(500 nM), which are inhibitors of the PI3 K/Akt/mTOR pathway, significantly attenuated the inhibition of autophagy and apoptosis caused by apelin-13. In conclusion, the findings of the present study suggest that Bcl-2 upregulation and mTOR signaling pathway activation lead to the inhibition of apoptosis and excessive autophagy. These effects are involved in apelin-13-induced neuroprotection against cerebral ischemia/reperfusion injury, both in vivo and in vitro. The study was approved by the Animal Ethical and Welfare Committee of Jining Medical University, China(approval No. 2018-JS-001) in February 2018. 相似文献
53.
54.
目的:探讨Zeste基因增强子(enhancer of zeste homolog 2,EZH2)对弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)RCHOP方案治疗的效果的预测价值。方法:纳入2017年1月至2018年5月南华大学附属第二医院80例接受RCHOP方案治疗的DLBCL患者,分析患者EZH2表达情况与治疗效果的关系,绘制EZH2预测治疗效果的ROC曲线,并对患者pCR与病理特征的关系进行讨论。结果:80例患者中EZH2高表达者49例,EZH2低表达者31例,DLBCL患者RCHOP治疗的pCR率为51.25%,其中EZH2高表达患者完全缓解(complete response,CR)、客观缓解率(objective response rate,ORR)均明显低于EZH2低表达患者(P<0.05);EZH2预测治疗效果的曲线下面积为0.874(P<0.05);pCR与性别、年龄、美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)得分、淋巴瘤国际预后指数(International Prognostic Index,IPI)得分、乳酸脱氢酶(lactate dehydrogenase,LDH)因素无相关关系(P>0.05);与Hans分型、EZH2表达水平存在一定的相关性(P<0.05)。结论:DLBCL患者EZH2低表达是RCHOP治疗后高pCR率的预测因子,在临床上有助于为DLBCL患者临床治疗提供更好的指导。 相似文献
55.
56.
《Clinical neurophysiology》2021,132(2):315-322
ObjectivePrevious studies have demonstrated voluntary movement alterations as well as motor cortex excitability and plasticity changes in patients with mild cognitive impairment (MCI). To investigate the pathophysiology of movement abnormalities in MCI, we tested possible relationships between movement abnormalities and primary motor cortex alterations in patients.MethodsFourteen amnestic MCI (aMCI) patients and 16 healthy controls were studied. Cognitive assessment was performed using clinical scales. Finger tapping was recorded by a motion analysis system. Transcranial magnetic stimulation was used to test the input/output curve of motor evoked potentials, intracortical inhibition, and short-latency afferent inhibition. Primary motor cortex plasticity was probed by theta burst stimulation. We investigated correlations between movement abnormalities, clinical scores, and cortical neurophysiological parameters.ResultsMCI patients showed less rhythmic movement but no other movement abnormalities. Cortical excitability measures were normal in patients, whereas plasticity was reduced. Movement rhythm abnormalities correlated with frontal dysfunction scores.ConclusionOur study in MCI patients demonstrated abnormal voluntary movement and plasticity changes, with no correlation between the two. Altered rhythm correlated with frontal dysfunction.SignificanceOur results contribute to the understanding of pathophysiological mechanisms of motor impairment in MCI. 相似文献
57.
The splanchnic anti-inflammatory pathway, the efferent arm of the endogenous inflammatory reflex, has been shown to suppress the acute inflammatory response of rats to systemic lipopolysaccharide (LPS). Here we show for the first time that this applies also to mice, and that the reflex may be engaged by a range of inflammatory stimuli. Experiments were performed on mice under deep anaesthesia. Half the animals were subjected to bilateral section of the splanchnic sympathetic nerves, to disconnect the splanchnic anti-inflammatory pathway, while the remainder underwent a sham operation. Mice were then challenged intravenously with one of three inflammatory stimuli: the toll-like receptor (TLR)-4 agonist, LPS (60 µg/kg), the TLR-3 agonist Polyinosinic:polycytidylic acid (Poly I:C, 1 mg/kg) or the TLR-2 and -6 agonist dipalmitoyl-S-glyceryl cysteine (Pam2cys, 34 µg/kg). Ninety minutes later, blood was sampled by cardiac puncture for serum cytokine analysis. The splanchnic anti-inflammatory reflex action was assessed by comparing cytokine levels between animals with cut versus those with intact splanchnic nerves. A consistent pattern emerged: Tumor necrosis factor (TNF) levels in response to all three challenges were raised by prior splanchnic nerve section, while levels of the anti-inflammatory cytokine interleukin 10 (IL-10) were reduced. The raised TNF:IL-10 ratio after splanchnic nerve section indicates an enhanced inflammatory state when the reflex is disabled. These findings show for the first time that the inflammatory reflex drives a coordinated anti-inflammatory action also in mice, and demonstrate that its anti-inflammatory action is engaged, in similar fashion, by inflammatory stimuli mimicking a range of bacterial and viral infections. 相似文献
58.
59.
目的探讨弥漫型大B细胞淋巴瘤Zeste同源物增强子2(EZH2)、X连锁凋亡抑制蛋白(XIAP)和生存素(Survivin)蛋白表达水平及意义。方法选取弥漫型大B细胞淋巴瘤组织92例作为观察组,同时选取反应性增生淋巴结组织50例作为对照组,采用免疫组化染色法检测EZH2、XIAP和Survivin蛋白表达。结果观察组EZH2、XIAP和Survivin蛋白阳性表达率分别为77.17%、55.43%和60.87%,明显高于对照组(P<0.05)。观察组临床分期Ⅲ~Ⅳ期EZH2、XIAP和Survivin蛋白表达阳性率分别为90.70%、86.05%和81.40%,明显高于临床分期Ⅰ~Ⅱ期(P<0.05);EZH2与XIAP、Survivin蛋白表达呈正相关(γ=0.547、0.360,P均<0.05),XIAP与Survivin蛋白表达呈正相关(γ=0.581,P<0.05)。结论弥漫型大B细胞淋巴瘤EZH2、XIAP和Survivin蛋白表达水平上调,与临床分期有一定关系,三者间存在相关关系。 相似文献
60.
Preeclampsia is a multifactorial vascular disease unique to human pregnancy. While genetic and antiangiogenic factors are important contributors to preeclampsia susceptibility, recent studies have shown that dysregulation and/or over-activation of the complement system has an integral role in disease etiology. Furthermore, the role of the coagulation cascade may be underappreciated in the development of the disease. Traditionally, for research purposes, the pool of preeclampsia cases has been divided into non-severe and severe disease depending on the onset and severity of the symptoms. However, of particular interest are a small but important minority of cases that present with symptoms likening to those of hemolysis, elevated liver enzymes and low platelets syndrome, atypical hemolytic uremic syndrome, or thrombotic thrombocytopenic purpura, all thrombotic microangiopathy (TMA) diseases, with the hallmark mechanisms of endothelial dysfunction and aberrant activation of complement and coagulation cascades. We therefore propose a third class, severe TMA-like preeclampsia to be included in the categorization of preeclampsia patients. Identifying these patients would target research, diagnostic differentiation, and novel treatment options to the subclass of patients with life-threatening disease that are most likely to benefit from next-generation drug development. 相似文献